Home/Filings/4/0001127602-25-019732
4//SEC Filing

O'Day Daniel Patrick 4

Accession 0001127602-25-019732

CIK 0000882095other

Filed

Jul 28, 8:00 PM ET

Accepted

Jul 29, 4:54 PM ET

Size

6.7 KB

Accession

0001127602-25-019732

Insider Transaction Report

Form 4
Period: 2025-07-28
O'Day Daniel Patrick
DirectorChairman & CEO
Transactions
  • Sale

    Common Stock

    2025-07-28$113.17/sh1,655$187,293614,070 total
  • Sale

    Common Stock

    2025-07-28$114.09/sh8,345$952,077605,725 total
Footnotes (3)
  • [F1]The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 28, 2025.
  • [F2]Sale prices reported for the transactions reported here range from $112.71 to $113.59. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
  • [F3]Sale prices reported for the transactions reported here range from $113.71 to $114.56. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

Issuer

GILEAD SCIENCES, INC.

CIK 0000882095

Entity typeother

Related Parties

1
  • filerCIK 0001638643

Filing Metadata

Form type
4
Filed
Jul 28, 8:00 PM ET
Accepted
Jul 29, 4:54 PM ET
Size
6.7 KB